13F 机构持仓

a16z Capital Management, L.L.C.

MENLO PARK CA · SEC CIK 0001540358

2026Q22026Q1 更早 9 个季度 🔒
$142.15亿2026Q2 申报市值
19持仓数
99.4%前十大占比 · 第一大 90.0%
4 / 1新建仓 / 清仓
申报市值走势$142.15亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

SPCX 90.0%
NAVN 4.5%
RVMD 1.2%
META 0.8%
FIG 0.8%
BIOA 0.6%
XYZ 0.5%
ERAS 0.4%
MAZE 0.4%
DMRA 0.2%

2026Q2 买入最多 按季末市值估算

SPCX 新建仓+$127.90亿
RBLX 新建仓+$1,493.11万
KLRA 新建仓+$308.42万
IP STRATEGY HOLD 新建仓+$9,722

2026Q2 卖出最多 按季末市值估算

FIG 减仓-$1.81亿
OMDA 减仓-$2,532.25万
NAUTILUS BIOTECH 减仓-$1,606.49万
IP STRATEGY HOLD 清仓-$2.18万

2026Q2 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▲占比股数变动股数变动估算买卖额操作
— IP STRATEGY HOLDINGS INC $00.00%0 -82,740-100.0% -$2.18万 清仓
— IP STRATEGY HOLDINGS INC $9,7220.00%4,137 4,137— $9,722 新建仓
DNA GINKGO BIOWORKS HOLDINGS INC $107.59万0.01%108,568 00.0% — 不变
KLRA KAILERA THERAPEUTICS INC $308.42万0.02%140,000 140,000— $308.42万 新建仓
BTGO BITGO HOLDINGS INC $345.17万0.02%666,356 00.0% — 不变
CAMP CAMP4 THERAPEUTICS CORP $928.77万0.07%2,125,339 00.0% — 不变
AKTS AKTIS ONCOLOGY INC $1,337.55万0.09%415,000 00.0% — 不变
RBLX ROBLOX CORP $1,493.11万0.11%274,570 274,570— $1,493.11万 新建仓
— NAUTILUS BIOTECHNOLOGY INC $1,694.79万0.12%9,063,054 -8,590,863-48.7% -$1,606.49万 减仓
OMDA OMADA HEALTH INC $2,532.24万0.18%1,153,639 -1,153,645-50.0% -$2,532.25万 减仓
DMRA DAMORA THERAPEUTICS INC $3,215.24万0.23%1,236,157 00.0% — 不变
MAZE MAZE THERAPEUTICS INC $5,079.44万0.36%1,702,225 00.0% — 不变
ERAS ERASCA INC $5,244.10万0.37%2,862,500 00.0% — 不变
XYZ BLOCK INC $7,726.90万0.54%1,016,697 00.0% — 不变
BIOA BIOAGE LABS INC $7,924.50万0.56%3,233,170 00.0% — 不变
FIG FIGMA INC $1.08亿0.76%5,983,308 -10,028,070-62.6% -$1.81亿 减仓
META META PLATFORMS INC $1.20亿0.84%212,531 00.0% — 不变
RVMD REVOLUTION MEDICINES INC $1.73亿1.21%921,099 00.0% — 不变
NAVN NAVAN INC $6.45亿4.54%28,218,676 00.0% — 不变
SPCX SPACE EXPLORATION TECHN CORP $127.90亿89.97%74,855,020 74,855,020— $127.90亿 新建仓